Autocrine motility factor/ phosphoglucose isomerase (AMF/PGI) promotes cell survival by the pAkt survival pathway. Its receptor, gp78/AMFR, is an E3 ubiquitin ligase implicated in endoplasmic reticulum (ER)-associated protein degradation. We demonstrate here that AMF/PGI also protects against thapsigargin (TG)-and tunicamycin (TUN)-induced ER stress and apoptosis. AMF/PGI protection against the ER stress response is receptor mediated as it is not observed in gp78/AMFRknockdown HEK293 cells. However, AMF/PGI protection against the ER stress response by TG and TUN was mediated only partially through PI3K/Akt activation. AMF/PGI reduction of the elevation of cytosolic calcium in response to either TG or inositol 1,4,5-trisphosphate receptor activation with ATP was gp78/AMFR-dependent, independent of mitochondrial depolarization and not associated with changes in ER calcium content. These results implicate regulation of ER calcium release in AMF/PGI protection against ER stress and apoptosis. Indeed, sequestration of cytosolic calcium with BAPTA-AM limited the ER stress response. Importantly, elevation of cytosolic calcium upon treatment with the calcium ionophore ionomycin, while not inducing an ER stress response, did prevent AMF/PGI protection against ER stress. By regulating ER calcium release, AMF/PGI interaction with gp78/AMFR therefore protects against ER stress identifying novel roles for these cancer-associated proteins in promoting tumor cell survival. Cell Death and Differentiation (2011) 18, 1057-1070 doi:10.1038/cdd.2010; published online 21 January 2011
The endoplasmic reticulum (ER) comprises a complex membranous network that has a crucial role in normal cellular function, particularly with regard to folding and post-translational modification of secretory and membrane proteins. 1 To accomplish its protein folding function, the ER contains high concentrations of chaperone proteins, which facilitate correct folding of nascent proteins. Many of these chaperones are calcium (Ca 2 þ ) dependent, and in fact, the ER contains high concentrations of Ca 2 þ and has an important role in intracellular Ca 2 þ homeostasis. 2 Disruption of ER function can occur as a result of a wide variety of cellular stress stimuli, many of them related to cancer development, reducing protein folding capacity, and leading to the buildup of unfolded and misfolded proteins within the ER. 3 The cell responds by inhibiting protein synthesis, enhancing protein folding capacity through expression of ER chaperone proteins, including BiP (also known as glucose regulated protein 78, GRP78), and degrading misfolded proteins through a process called ER-associated degradation (ERAD). This coordinated biochemical response to the accumulation of unfolded and/or misfolded proteins within the ER is termed the unfolded protein response (UPR). 4 Induction of the UPR occurs when the presence of unfolded proteins in the ER exceeds the capacity of the ER to correctly fold these proteins. UPR is associated with a number of normal biological processes, such as induction of antibody production in B cells, as well as with disease states in which it disrupts cell function and induces cell death. 5 Induced in response to hypoxia, nutrient deprivation and low pH of the tumor microenvironment, ER stress contributes to tumor cell survival and can be required for tumor growth; indeed, expression of various ER chaperones, including BiP, is upregulated in various cancers. 6 Both inhibition of UPR, resulting in a limited ability of the cell to deal with the stressful environment, or enhancing stress and overloading the UPR represents a possible approach to drive cancer cells towards apoptosis. 7 However, effectiveness of any such anti-cancer strategy will be dependent on understanding the mechanisms underlying cancer cell resistance to ER stress induction.
In the event of prolonged or severe ER stress that is not resolved, the UPR switches to initiation of apoptosis. 8 Certain components of the UPR are strongly linked to induction of ER stress-induced apoptosis. In this regard, CHOP is induced by all three arms of the UPR through XBP1, ATF4 and ATF6 transcription factors, and is required in many instances for ER stress-induced apoptosis. 9 ER stress is also associated with the release of ER Ca 2 þ , whose uptake by mitochondria is a critical regulator of cellular Ca 2 þ homeostasis and of the mitochondrial apoptosis pathway. 10, 11 Indeed, prolonged ER stress conditions cause a slow but sustained increase in mitochondrial matrix free Ca 2 þ , that upon reaching a critical threshold is one of the strongest inducers of pro-apoptotic mitochondrial membrane permeabilization. 12 Truncated sarcoplasmic reticulum Ca 2 þ ATPase 1 has been shown to promote pro-apoptotic ER-mitochondria Ca 2 þ transfer during ER stress. 13 However, other mechanisms regulating this process remain poorly understood.
AMF/PGI is a glycolytic enzyme that also functions as an extracellular cytokine following secretion by a non-classical mechanism. Autocrine activation of its receptor gp78/AMFR has been extensively associated with tumor cell motility and metastasis.
14 AMF/PGI overexpression in NIH-3T3 cells has been shown to induce cellular transformation and tumorigenicity, as well as tumor cell survival by PI3K/Akt signaling. 15 In addition to its role as the AMF/PGI receptor, gp78/AMFR is also an ER membrane-anchored ubiquitin ligase (E3) that is a key component of the ERAD pathway. 14 To specifically assess whether AMF/PGI regulates ER-associated survival, we tested its ability to protect against the ER stress response. We show that exogenous AMF/PGI protects against ER stress and associated cell death, and that this activity is dependent on expression of its receptor, gp78/AMFR. We further demonstrate that PI3K/Akt signaling only partially regulates AMF/PGI protection against ER stress and describe a novel role for gp78/AMFR-mediated AMF/PGI regulation of ER Ca 2 þ release that functions to limit ER stress and promote cell survival.
Results
AMF/PGI treatment prevents the tunicamycin and thapsigargin-induced ER stress response and associated apoptotic events. Incubation of Cos7 cells with tunicamycin (TUN), an inhibitor of N-glycosylation, or thapsigargin (TG), a sarco/endoplasmic reticulum Ca 2 þ -ATPase (SERCA) inhibitor that prevents ER Ca 2 þ uptake resulted in the disruption of the tubular calnexin-labeled ER network and its condensation into large vacuoles and densely labeled aggregates. However, in cells pretreated with 24 mg/ml AMF/PGI for 8 h, TUN or TG no longer disrupted the tubular ER network or induced ER vacuoles (Figure 1a ). TUN and TG increased expression levels of the major ER chaperone proteins BiP and CHOP, both associated with the ER stress response. Pretreatment of the cells with AMF/PGI for 8 h prevented increased BiP and CHOP expression induced by either TUN or TG (Figure 1b) . AMF/PGI therefore protects against TUN and TG-induced ER stress. ER stress-induced cell death was further characterized by PI/Annexin V double staining by both flow cytometry and immunofluorescence ( Figure 1c and Supplementary Figure 1) . AMF/PGI pretreatment significantly reduced the number of dead Annexin V/PI-positive cells, demonstrating the ability of AMF/PGI to promote cell survival upon induction of ER stress.
To assess the cytosolic expression of the apoptosisassociated proteins, cleaved caspase-3 and mitochondrial cytochrome c, cells were sub-fractionated into cytosol, nuclei, ER/plasma membrane and mitochondrial fractions using a-tubulin, a-fibrilarin, calnexin and cytochrome c as markers, respectively. The cytosolic and mitochondrial markers, a-tubulin and cytochrome c, respectively, were highly enriched in these fractions and subsequent analyses were limited to these subcellular fractions. Prolonged TUN and TG treatment to 24 h induced mitochondrial cytochrome c release to cytosol and upregulation of cleaved caspase-3 in the cytosolic fraction, consistent with the occurrence of apoptotic death in cells subjected to chronic ER stress. In contrast, AMF/PGI pretreatment prevented TUN and TG-induced cytosolic cytochrome c release and caspase-3 cleavage, suggesting that AMF/PGI-mediated protection from ER stress is caspase-3 dependent and occurs through the mitochondrial pathway ( Figure 2a ). Confocal images showed that the extensive overlap of cytochrome c with the mitochondrial marker Oxphos V in untreated cells was lost upon treatment with either TUN or TG that resulted in cytochrome c release to cytosol. This was prevented in AMF/PGI pretreated cells that still presented extensive overlap between cytochrome c and Oxphos V labeling even in TUN-or TG-treated cells (Figure 2b) .
The DNA-damaging topoisomerase II inhibitor etoposide 16 does not increase expression of BiP and CHOP, but does induce expression of cleaved caspase-3. This is consistent with previous reports that etoposide induced cell apoptosis does not occur through the ER stress pathway. 17 AMF/PGI protected against cell death induced by etoposide, TG and TUN and also inhibited etoposide-induced upregulation of cleaved caspase-3 (Figures 3a and b) . This suggests that AMF/PGI protects against cell death induced not only through the ER stress pathway but also through other mechanisms, consistent with previous reports that AMF/PGI overexpression protects against serum starvation-induced cell death through the PI3K/Akt pathway.
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Gp78/AMFR mediates AMF/PGI protection against the ER stress response and apoptosis. The cell surface receptor for AMF/PGI, gp78/AMFR is localized both at the cell surface and in the ER, in which it functions as an E3 ubiquitin ligase in ERAD.
14 To determine the role of gp78/ AMFR in AMF/PGI protection against the ER stress response, we generated stable gp78/AMFR-specific microRNA transfected HEK293 cells (miR2 and miR3) that show a 60-70% reduction in gp78/AMFR expression compared with non-targeted miRNA control transfected HEK293 cells (NTC1 and NTC2) by western blot analysis (Figure 4a) . Using flow cytometry, we found that cell surface gp78/AMFR expression showed 60-80% reduction in microRNA-transfected HEK293 cells (miR2 and miR3) compared with non-targeted miRNA control transfected HEK293 cells (NTC1 and NTC2) ( Figure 4b ). As observed previously in Cos7 cells, AMF/PGI decreased TUN and TG-induced CHOP and cleaved caspase-3 expression in non-targeted control HEK293 cells (NTC1 and NTC2). However, in gp78/AMFR-specific microRNA transfected HEK293 cells (miR2 and miR3), AMF/PGI had no effect on ER stress-induced CHOP and cleaved caspase-3 expression (Figure 4c ). This indicates that AMF/PGI protection against ER stress and associated apoptosis is mediated by gp78/AMFR. AMF/PGI prevents the ER stress response in part through the PI3K/Akt cell survival pathway. AMF/PGI has previously been shown to promote cell survival through the PI3K/Akt pathway. 15 To determine the role of PI3K/Akt signaling in AMF/PGI prevention of the ER stress response, we evaluated the effect of AMF/PGI on CHOP, BiP and cleaved caspase-3 expression upon pretreatment with the PI3K inhibitor, LY294002. As previously reported in NIH-3T3 and MDA-435 cells, 15, 18 AMF/PGI treatment induced activation of pAkt in Cos7 cells that was prevented by the PI3K inhibitor LY294002 ( Figure 5 ). However, LY294002 treatment only partially reversed the inhibition by AMF/PGI of induction of the ER stress markers BiP and CHOP and of cleaved caspase-3 upon TUN and TG treatment. Expression of all three markers was significantly elevated relative to treatment of ER-stressed cells with AMF/PGI alone, indicating that PI3K inhibition is partially reversing the ability of AMF/PGI to protect against the ER stress response. However, marker expression levels were reduced relative to levels induced by TUN and TG in the absence of AMF/PGI. This suggests that AMF/PGI protects against the ER stress response and associated cell apoptosis only partially through the PI3K/Akt cell survival pathway and that other mechanisms must also be involved. AMF/PGI decreases Ca 2 þ release from the ER. We then analyzed the influence of AMF/PGI on cytosolic Ca 2 þ dynamics in the absence of mitochondrial interactions, by treating the cells with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a proton ionophore that uncouples the mitochondrial proton gradient and inhibits mitochondrial Ca 2 þ uptake. 21 In control cells, addition of 1 mM CCCP induced a small, but reproducible increase in cytosolic Ca 2 þ that corresponded to a slight downward deflection in [Ca 2 þ ] m measured with Rhod-2 in untreated and AMF/PGI-pretreated cells (not shown). To investigate whether the inhibition of mitochondrial Ca 2 þ uptake affected AMF/PGI regulation of ER Ca 2 þ release induced by acute SERCA inhibition and IP3R activation, we added TG and ATP 6-8 min after CCCP stimulation (Figures 8a and b) . In CCCP prestimulated cells, the peak amplitude of the Ca 2 þ transient, induced by both TG and ATP, was increased because of inhibition of mitochondrial Ca 2 þ uptake. However, AMF/PGI treatment (Figure 10b) . AMF/PGI, therefore prevents ER stress and promotes cell survival through regulation of ER calcium release.
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Discussion
Previous reports have described a role for AMF/PGI in protection against apoptosis and cell death. 15, 25 The AMF/PGI receptor, gp78/AMFR, is an ER membraneanchored ubiquitin ligase (E3) that is a key component of the ERAD machinery involved in ubiquitination of ER proteins, 26, 27 thereby suggesting a possible role in protecting cells against ER stress. In this study, we demonstrate that AMF/PGI protects against ER stress and associated apoptosis by the intermediary of its receptor, gp78/AMFR. Gp78/AMFR has been localized to both the plasma membrane and smooth ER by electron microscopy and to the plasma membrane by immunofluorescent labeling of viable cells using the gp78/AMFR-specific 3F3A antibody that competes with AMF/PGI for cell surface binding. 18, 28 Here, we show that upon gp78/AMFR knockdown, HEK293 cells present reduced cell surface 3F3A labeling and extracellular AMF/PGI no longer prevents ER stress-induced expression of BiP, CHOP and cleaved caspase-3. In addition, although AMF/PGI treatment dramatically attenuated the peak amplitude of ATP-evoked [Ca 2 þ ] cyt in non-targeted control cells, it had no significant effect on the peak amplitude of ATP-evoked [Ca 2 þ ] cyt in gp78/AMFR microRNA stably transfected knockdown cells. We have previously reported that expression of the gp78/AMFR ubiquitin ligase substrate KAI1 is increased and responsible for reduced proliferation of these gp78/AMFR knockdown cells. 29 Loss of gp78/AMFR in these cells therefore affects both its ubiquitin ligase activity and its receptor function mediating AMF/PGI prosurvival activity.
Protein kinase B (PKB)/Akt is a central factor in regulating many signaling pathways controlling cell metabolism, growth and survival. 30 AMF/PGI activation of pAkt has previously been shown to mediate AMF/PGI anti-apoptosis function. 15, 18, 25 Indeed, the ability of AMF/PGI to protect against etoposide-induced cell death that is not associated with induction of ER stress, confirms that the anti-apoptotic activity of AMF/PGI is not limited to the ER stress response. Etoposide-induced apoptosis is prevented by inhibition of the PI3K-Akt pathway 31 consistent with previous reports that AMF/PGI protects against serum starvation-induced cell death in NIH-3T3 fibroblasts by PI3K/Akt signaling. 15 However, although we found that AMF/PGI treatment induced activation of pAkt, PI3K inhibition with LY290042 only partially prevents AMF/PGI protection against induction of ER stress markers or AMF/PGI attenuation of ER Ca 2 þ release. This suggests that pAkt activation may be only one of the mechanisms by which AMF/PGI protects against ER stress.
The release of Ca 2 þ from ER and local interactions between the ER and mitochondria facilitating the transfer of Ca 2 þ from the ER to mitochondria represent important mechanisms of apoptosis regulation. 11 The gp78/AMFRpositive smooth ER domain is closely associated with mitochondria and this interaction is regulated by [Ca 2 þ ] cyt . 24, 32 In response to TG and TUN, AMF/PGI reduced the peak amplitude although not total (AUC) elevation of [Ca 2 þ ] cyt and importantly affected the rate of Ca 2 þ uptake to mitochondria. AMF/PGI affect on [Ca 2 þ ] cyt elevation was not however affected by mitochondrial uncoupling, suggesting that it is not related to mitochondrial association of the gp78/AMFRlabeled smooth ER domain. 24, 32 It was also not associated with changes in ER Ca 2 þ content. AMF/PGI interaction with gp78/AMFR, therefore, regulates ER Ca 2 þ release upon ER stress. To test whether [Ca 2 þ ] cyt regulates the ER stress response, we first treated cells with the cell permeable Ca 2 þ chelator, BAPTA-AM, and showed that it significantly reduced the expression of the ER stress markers BiP, CHOP and cleaved caspase-3 in response to either TG or TUN. Elevation 33 Regulation of ER Ca 2 þ release by AMF/PGI defines a novel role for an extracellular cytokine in regulation of cellular Ca 2 þ homeostasis. Overexpression and secretion of AMF/PGI by tumor cells induce autocrine stimulation of tumor cell motility, cell transformation and tumorigenicity; 15 elevated circulating AMF/PGI levels are found in the serum of cancer patients. 34, 35 AMF/PGI protects against chemotherapeutic agents in vitro as well as in implanted tumors wherein it protects against paclitaxelmediated cell death. 25, 36 AMF/PGI interaction with gp78/ AMFR may therefore contribute to tumor cell survival and resistance to chemotherapy by limiting the ER stress response of tumor cells growing in the harsh conditions of the tumor microenvironment.
Materials and Methods
Antibodies and chemicals. The rat IgM 3F3A mAb against gp78/AMFR was as described. 37 Antibodies to OxphosV were from Molecular Probes (Carlsbad, CA, USA), antibodies to CHOP, cleaved caspase 3, pAkt and Akt from Cell Signaling (Danvers, MA, USA) and to calnexin, tubulin, fibrilarin, BiP and cytochrome c from Sigma (St. Louis, MO, USA). Cross-absorbed Alexa488, Alexa568 and Alexa647 or HRP-conjugated anti-mouse and anti-rabbit IgG secondary antibodies, Alexa647-conjugated anti-rat IgM were from Molecular Probes. HRP-conjugated rat IgM was from Jackson ImmunoResearch (West Grove, PA, USA). BAPTA-AM and LY294002 were from Calbiochem (Gibbstown, NJ, USA). Rhod-2 AM and pluronic F-127 (PAc) and MitoTracker Green were from Invitrogen (Carlsbad, CA, USA). AMF/PGI (P9544), CCCP, etoposide, ionomycin, TUN, TG, ATP, Fura-2 AM and other reagents were from Sigma. Cell culture, constructs and treatments. Cos7 and HEK293 cells were grown in DMEM supplemented with 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2 mM l-glutamine and 25 mM HEPES buffer at 371C in a humid atmosphere (5% CO 2 and 95% air), and transfected using Effectene transfection reagent (Qiagen, Hilden, Germany). For AMF/PGI pretreatment, cells were starved overnight and incubated with fresh media containing AMF/PGI for 8 h. Cells were subsequently treated with 2 mg/ml TUN and 3 mM TG for 8 or 24 h, or 100 mM etoposide for 24 h in media containing AMF/PGI. To generate stable gp78/AMFR knockdown cell lines, pre-miRNA sequences for gp78/AMFR and non-targeting control miRNAs were cloned into pcDNA6.2-GW/ þ EmGFP-miR (Invitrogen). The microRNA nucleotide sequences targeting human gp78/AMFR (GenBank accession number: NM_001144.4) correspond to the following amino acid positions relative to the initiating methionine: miR2, 271-278; miR3, 293-300. HEK293 cells were transfected with control or gp78/AMFR miRNA vectors and selected with 5 mg/ml blasticidin. Clones were sorted by flow cytometry and gp78/AMFR downregulation confirmed by immunoblotting and flow cytometry. The KDEL-ss-mRFP plasmid in pCDNA3.1 vector was provided by Erik Snapp (Albert Einstein College of Medicine, Bronx, NY, USA).
Immunofluorescence. Cells were fixed with 3% paraformaldehyde, permeabilized with 0.2% Triton X-100 and labeled with antibodies to OxphosV and cytochrome c followed by species-specific fluorescent-conjugated secondary antibodies and the nuclear stain Hoechst 33257. Cells labeled with antibodies to calnexin were fixed by precooled methanol-acetone (80-20%, v/v, À801C).
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Images were obtained using excitation with 488, 543 and 633 nm laser lines and a Â 100 (NA 1.4) plan apochromat objective of an Olympus FV1000 confocal microscope (Olympus Canada, Markham, ON, Canada) and acquired using the Hi-Lo function. Cytochrome c distribution to mitochondria by mask overlay (% intensity of cytochrome c labeling that overlapped with OxphosV labeled mitochondria) was quantified using ImagePro image analysis software (Media Cybernetics, Bethesda, MD, USA).
Annexin V/PI double staining and gp78/AMFR surface labeling. Labeling of cells for Annexin V/propidium iodide (PI) was performed according to the manufacturer's instructions (Roche, Basel, Switzerland). Cells were visualized by confocal microscopy ( Â 10 objective) using dual wavelength excitation at 488 and 568 nm, and detection at 515-565 nm and 600-670 nm or by flow cytometry using 488 nm excitation and a 515 nm bandpass filter for fluorescence detection, and a 600 nm filter for PI detection. Cell surface gp78/AMFR was labeled with the 3F3A anti-gp78/AMFR antibody at 41C followed by Alexa-647 anti-rat IgM secondary antibody and PI to exclude dead cells by flow cytometry analysis, as previously described. 18 Cell fractionation and western blots. Cell fractionation was performed using the mitochondrial isolation kit (Qiagen). Equal amounts of cell lysates were separated on 12% SDS-PAGE gels, transferred to nitrocellulose membranes and immunoblotted with antibodies to CHOP, calnexin, cytochrome c, cleaved caspase 3, a-tubulin, a-fibrilarin or b-actin, followed by appropriate HRP-conjugated secondary antibodies. Chemiluminescence was revealed using ECL (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) and densitometry performed using Quantity One V4.62 software (Bio-Rad Laboratories, Hercules, CA, USA).
Cell viability and cytotoxicity assay. The growth inhibitory effects of TUN, TG and etoposide were determined in Cos7 cells, and quantified by measuring cell viability using a crystal violet colorimetric assay. 36 Cells were seeded at 5 Â 10 3 cells/well in 96-well microtiter plates and allowed to attach overnight. All drugs were dissolved in DMSO, and cells were treated either with the drugs alone, or in the presence of AMF/PGI (24 mg/ml). Control cells received growth media or AMF/PGI (24 mg/ml) only. Cell growth inhibition was quantified 48 h post treatment. Eight-plicate cultures were analyzed in three separate experiments and the results are presented as a percentage of treated relative to untreated control cells.
Cytosolic Ca
2 þ measurements. Cells were plated in the wells of an Ibidi mSlide VI flow chamber (ibidi GmbH, Martinsried (Munich), Germany, Cat No. 80606). Cells were incubated with fresh medium containing Fura-2 AM (5 mM) supplied with 0.02% Pac to help disperse AM ester for 45 min at 371C under an atmosphere of 5% CO 2 . The flow chamber was placed on an epifluorescence/phase contrast Olympus IX71 microscope with a Â 40 UApo objective in a heated environmental chamber. Imaging experiments were performed at 371C. Extracellular solutions contained 125 mM NaCl, 20 mM HEPES, 5 mM KCl, 1.5 mM MgCl 2 and 10 mM glucose, pH 7.4 24 and were perfused rapidly using a mini pump. Cells were illuminated at alternating excitation wavelengths of 340 and 380 nm with a PTI high-speed random access monochromator (Photon Technology International, Birmingham, NJ, USA). Only cells expressing a similar degree of initial Fura-2 loading were analyzed. The emitted fluorescence was recorded at 510 nm with a Photometric Cascade 512B CCD camera, and the calculated free [Ca 2 þ ] cyt determined using a cell-free calibration curve. Images were analyzed using InVivo Analyzer V3.0 software (Media Cybernetics).
Mitochondrial Ca
2 þ measurements. Cells were plated in the wells of an Ibidi mSlide VI flow chamber (ibidi GmbH, Cat No. 80606). Cells were incubated with fresh medium containing Rhod-2 AM (5 mM) supplied with 0.02% Pac in a twostep cold/warm loading protocol (30 min at 41C and 30 min at 371C) 38 for selective mitochondrial loading. Washed cells were analyzed in an epifluorescence/phase contrast Olympus IX71 microscope with a Â 40 UApo objective in a heated environmental chamber at 371C. Cells were illuminated at excitation wavelengths of 545 nm using a PTI high-speed random access monochromator (Photon Technology International). The emitted fluorescence was recorded at 575 nm with a Photometric Cascade 512B CCD camera (Photometrics, Tucson, AZ, USA). Images were analyzed using InVivo Analyzer V3.0 software (Media Cybernetics). Only cells expressing a similar degree of initial Rhod-2 loading were analyzed. Rhod-2 localization was visualized by counterstaining Rhod-2-loaded cells with a MitoTracker Green, and dye colocalization was confirmed by confocal microscopy.
ER Ca
2 þ measurement. Cells were plated on 22 Â 22 mm coverslips in a 35 mm dish and transiently transfected with the fluorescence resonance energy transfer (FRET)-based D1ER cameleon. 22, 39 Imaging experiments were performed at 371C using a chamber system heater controller (Harvard Apparatus, Holliston, MA, USA), as described. 39 Extracellular solutions contained 125 mM NaCl, 20 mM HEPES, 5 mM KCl, 1.5 mM MgCl 2 , 10 mM glucose and 2 mM CaCl 2 , pH 7.4. The cyan fluorescent protein (CFP) component of the probe was excited using a S430/25x filter (Chroma, Bellows Falls, VT, USA). CFP and FRET (i.e. YFP) emission were alternately collected using S470/30 m and S535/30 m filters mounted in a Sutter Lambda 10-2 filter wheel (Sutter Instrument Co., Novato, CA, USA). Changes in [Ca 2 þ ] ER were expressed as the FRET-to-CFP emission ratio, which is directly proportional to [Ca 2 þ ] cyt . Images were analyzed using SlideBook software (Intelligent Imaging Innovations, Denver, CO, USA).
Statistical analyses. Data are presented as mean ± S.E.M. One-way ANOVA was used for group-paired observations. Differences were considered statistically significant when Po0.05.
